title: Benefits and risks associated with thrombolysis for pulmonary embolism.
authors.affiliation: Section of Pulmonary and Critical Care Medicine, Boston University School of Medicine, Boston, Massachusetts.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Bradford
authors.affiliation: Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
authors.forename: Neill K J
authors.initials: NK
authors.lastname: Adhikari
authors.affiliation: Interdepartmental Division of Critical Care, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Jan O
authors.initials: JO
authors.lastname: Friedrich
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced*; D011655:Pulmonary Embolism / Q000188:drug therapy*; D015912:Thrombolytic Therapy
chemical_list: D000925:Anticoagulants; D005343:Fibrinolytic Agents